GLP-1 weight-loss drugs have dominated healthcare headlines in 2024, marked by expanded employer coverage, dynamic pricing changes, and pharmaceutical giants like Novo Nordisk (NVO) and Eli Lilly ...
the company said late on Tuesday. Eli Lilly's Alzheimer's treatment approved in China Boards, Policy & Regulationcategory· December 18, 2024 The Johnson & Johnson drug Darzalex showed promise in ...